Organon (OGN) Stock Forecast & Price Target

Compare

1,065 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

OGN Analyst Ratings

Hold

1 Buy

0 Hold

1 Sell

Based on 2 analysts giving stock ratings to

Organon

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

OGN Stock 12 Month Forecast

Average Price Target

$16.00

▲(72.41% Upside)

Based on 2 Wall Street analysts offering 12 month price targets for Organon in the last 3 months. The average price target is $16.00 with a high forecast of $18.00 and a low forecast of $14.00. The average price target represents a 72.41% change from the last price of $9.28.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","19":"$19","10.75":"$10.75","13.5":"$13.5","16.25":"$16.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$18.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,10.75,13.5,16.25,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.99,11.52923076923077,12.068461538461538,12.607692307692307,13.146923076923077,13.686153846153847,14.225384615384616,14.764615384615384,15.303846153846154,15.843076923076923,16.38230769230769,16.92153846153846,17.46076923076923,{"y":18,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.99,11.375384615384615,11.760769230769231,12.146153846153846,12.531538461538462,12.916923076923077,13.302307692307693,13.687692307692307,14.073076923076924,14.458461538461538,14.843846153846155,15.22923076923077,15.614615384615384,{"y":16,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.99,11.221538461538461,11.453076923076923,11.684615384615384,11.916153846153847,12.147692307692308,12.37923076923077,12.61076923076923,12.842307692307692,13.073846153846155,13.305384615384614,13.536923076923078,13.768461538461539,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.09,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.36,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.22,"date":1733011200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":14.58,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":15.21,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":14.84,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.07,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.41,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.23,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":10.03,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":9.73,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.42,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.99,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$18.00

Average Price Target$16.00

Lowest Price Target$14.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Chris Schott

J.P. Morgan

$14

Sell

50.86%

Upside

Reiterated

10/16/25

J.P. Morgan Keeps Their Sell Rating on Organon (OGN)

Veda Pharmyne

TR | OpenAI - 4o

$11→$10.5

Hold

13.15%

Upside

Reiterated

10/09/25

AI Generated ArticleAI Generated Article

David Amsellem

Piper Sandler

$18

Buy

93.97%

Upside

Reiterated

08/29/25

Piper Sandler Sticks to Its Buy Rating for Organon (OGN)

Navann Ty

Exane BNP Paribas

$29→$16

Buy

72.41%

Upside

Reiterated

05/22/25

Organon Co. (OGN) PT Lowered to $16 at BNP Paribas ExaneBNP Paribas Exane analyst Navaan Ty lowered the price target on Organon Co. (NYSE: OGN) to $16.00 (from $29.00) while maintaining a Outperform rating.

Terence Flynn

Morgan Stanley

$15→$10

Hold

7.76%

Upside

Reiterated

05/04/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (NASDAQ: AMGN), Organon (NYSE: OGN) and Cardinal Health (NYSE: CAH)

Umer Raffat

Evercore ISI

―

Hold

―

Downgraded

05/02/25

Evercore ISI downgrades Organon (OGN) to a Hold

Jason Gerberry

Bank of America Securities

$11→$10

Sell

7.76%

Upside

Reiterated

05/01/25

Organon price target lowered to $10 from $11 at BofAOrganon price target lowered to $10 from $11 at BofA

Steve Scala

TD Cowen

$19→$15

Hold

61.64%

Upside

Reiterated

04/22/25

Organon Co. (OGN) PT Lowered to $15 at TD CowenTD Cowen analyst Steve Scala lowered the price target on Organon Co. (NYSE: OGN) to $15.00 (from $19.00) while maintaining a Hold rating.

Balaji Prasad

Barclays

$24

Buy

158.62%

Upside

Reiterated

03/10/25

Barclays Sticks to Its Buy Rating for Organon (OGN)

Chris Shibutani

Goldman Sachs

$20→$19

Hold

104.74%

Upside

Reiterated

02/14/25

Organon Co. (OGN) PT Lowered to $19 at Goldman SachsGoldman Sachs analyst Chris Shibutani lowered the price target on Organon Co. (NYSE: OGN) to $19.00 (from $20.00) while maintaining a Neutral rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Chris Schott

J.P. Morgan

$14

Sell

50.86%

Upside

Reiterated

10/16/25

J.P. Morgan Keeps Their Sell Rating on Organon (OGN)

Veda Pharmyne

TR | OpenAI - 4o

$11→$10.5

Hold

13.15%

Upside

Reiterated

10/09/25

AI Generated ArticleAI Generated Article

David Amsellem

Piper Sandler

$18

Buy

93.97%

Upside

Reiterated

08/29/25

Piper Sandler Sticks to Its Buy Rating for Organon (OGN)

Navann Ty

Exane BNP Paribas

$29→$16

Buy

72.41%

Upside

Reiterated

05/22/25

Terence Flynn

Morgan Stanley

$15→$10

Hold

7.76%

Upside

Reiterated

05/04/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (NASDAQ: AMGN), Organon (NYSE: OGN) and Cardinal Health (NYSE: CAH)

Umer Raffat

Evercore ISI

―

Hold

―

Downgraded

05/02/25

Evercore ISI downgrades Organon (OGN) to a Hold

Jason Gerberry

Bank of America Securities

$11→$10

Sell

7.76%

Upside

Reiterated

05/01/25

Organon price target lowered to $10 from $11 at BofAOrganon price target lowered to $10 from $11 at BofA

Steve Scala

TD Cowen

$19→$15

Hold

61.64%

Upside

Reiterated

04/22/25

Organon Co. (OGN) PT Lowered to $15 at TD CowenTD Cowen analyst Steve Scala lowered the price target on Organon Co. (NYSE: OGN) to $15.00 (from $19.00) while maintaining a Hold rating.

Balaji Prasad

Barclays

$24

Buy

158.62%

Upside

Reiterated

03/10/25

Barclays Sticks to Its Buy Rating for Organon (OGN)

Chris Shibutani

Goldman Sachs

$20→$19

Hold

104.74%

Upside

Reiterated

02/14/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Organon

1 Month

xxx

Success Rate

6/13 ratings generated profit

Average Return

+2.45%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 46.15% of your transactions generating a profit, with an average return of +2.45% per trade.

3 Months

xxx

Success Rate

8/13 ratings generated profit

Average Return

+2.05%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +2.05% per trade.

1 Year

Jason GerberryBank of America Securities

Success Rate

10/13 ratings generated profit

Average Return

+19.07%

reiterated a sell rating 6 months ago

Copying Jason Gerberry's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +19.07% per trade.

2 Years

xxx

Success Rate

11/13 ratings generated profit

Average Return

+27.97%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 84.62% of your transactions generating a profit, with an average return of +27.97% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OGN Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, OGN has received 1 Buy Ratings, 5 Hold Ratings, and 1 Sell Ratings. OGN average Analyst price target in the past 3 months is 16.00.

Each month's total comprises the sum of three months' worth of ratings.

OGN Financial Forecast

OGN Earnings Forecast

Next quarter’s earnings estimate for OGN is $0.94 with a range of $0.89 to $0.97. The previous quarter’s EPS was $1.00. OGN beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year OGN has Preformed in-line its overall industry.

OGN Sales Forecast

Next quarter’s sales forecast for OGN is $1.57B with a range of $1.56B to $1.59B. The previous quarter’s sales results were $1.59B. OGN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year OGN has Preformed in-line its overall industry.

OGN Stock Forecast FAQ

What is OGN’s average 12-month price target, according to analysts?

Based on analyst ratings, Organon & Co.’s 12-month average price target is 16.00.

What is OGN’s upside potential, based on the analysts’ average price target?

Organon & Co. has 72.41% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is OGN a Buy, Sell or Hold?

Organon & Co. has a consensus rating of Hold which is based on 1 buy ratings, 0 hold ratings and 1 sell ratings.

What is Organon & Co.’s price target?

The average price target for Organon & Co. is 16.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $18.00 ,the lowest forecast is $14.00. The average price target represents 72.41% Increase from the current price of $9.28.

What do analysts say about Organon & Co.?

Organon & Co.’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.

How can I buy shares of OGN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Organon (OGN) Stock Forecast & Price Target

OGN Analyst Ratings

OGN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Organon

OGN Analyst Recommendation Trends

OGN Financial Forecast

OGN Earnings Forecast

OGN Sales Forecast

OGN Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts